ClearPoint Neuro (CLPT) Property, Plant & Equipment (Net) Growth (3y) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PP&E (Net) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 10.07% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 8.57% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 9.71% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 17.92% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 3.47% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 13.19% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 9.97% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 9.80% |
| 10 | ClearPoint Neuro | 375.84 Mn | 340.24 Mn | 7.76 Mn | 45.35% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 45.35% |
| Dec 31, 2025 | 48.15% |
| Sep 30, 2025 | 49.79% |
| Jun 30, 2025 | 43.10% |
| Mar 31, 2025 | 45.48% |
| Dec 31, 2024 | 54.94% |
| Sep 30, 2024 | 55.59% |
| Jun 30, 2024 | 64.20% |
| Mar 31, 2024 | 66.47% |
| Dec 31, 2023 | 63.29% |
| Sep 30, 2023 | 60.61% |
| Jun 30, 2023 | 58.34% |
| Mar 31, 2023 | 34.59% |
| Dec 31, 2022 | 21.71% |
| Sep 30, 2022 | 9.87% |
| Jun 30, 2022 | 13.48% |
| Mar 31, 2022 | 12.44% |
| Dec 31, 2021 | 12.58% |
| Sep 30, 2021 | 11.82% |
| Jun 30, 2021 | 6.49% |
| Mar 31, 2021 | -9.03% |
| Dec 31, 2020 | 6.02% |
| Dec 31, 2019 | 10.84% |
| Sep 30, 2019 | 3.26% |
| Jun 30, 2019 | -4.41% |
| Mar 31, 2019 | 2.79% |
| Dec 31, 2018 | -5.00% |
| Sep 30, 2018 | -13.37% |
| Jun 30, 2018 | -12.60% |
| Mar 31, 2018 | -1.58% |
| Dec 31, 2017 | -17.86% |
| Dec 31, 2016 | -28.64% |
| Sep 30, 2016 | -29.66% |
| Jun 30, 2016 | -23.48% |
| Mar 31, 2016 | -28.37% |
| Dec 31, 2015 | -30.05% |
| Sep 30, 2015 | -27.17% |
| Jun 30, 2015 | -29.54% |
| Mar 31, 2015 | -29.45% |
| Dec 31, 2014 | -26.55% |